Danaher Corporation (NYSE:DHR) shares fell to a low of $253.06 before closing at $253.58. Intraday shares traded counted 2.33 million, which was 5.8% higher than its 30-day average trading volume of 2.47M. DHR’s previous close was $252.67 while the outstanding shares total 713.20M. The firm has a beta of 0.70, a 12-month trailing P/E ratio of 39.94, and a growth ratio of 2.48. The stock’s Relative Strength Index (RSI) is 57.28, with weekly volatility at 1.63% and ATR at 4.75. The DHR stock’s 52-week price range has touched low of $155.61 and a $261.43 high. The stock traded higher over the last trading session, gaining 0.36% on 05/14/21.
Investors have identified the Diagnostics & Research company Danaher Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $180.22 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Danaher Corporation (DHR) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 14.01 billion total, with 6.82 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 8.98 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on DHR sounds very interesting.
Is the stock of DHR attractive?
In related news, Director, LOHR WALTER G sold 4,350 shares of the company’s stock in a transaction that recorded on May 07. The sale was performed at an average price of 259.32, for a total value of 1,128,042. As the sale deal closes, the Executive Vice President, Weidemanis Joakim now sold 17,169 shares of the company’s stock, valued at 4,442,633. Also, SVP, Human Resources, Lalor Angela S sold 3,092 shares of the company’s stock in a deal that was recorded on Apr 23. The shares were price at an average price of 255.79 per share, with a total market value of 790,903. Following this completion of acquisition, the SVP & General Counsel, Ellis Brian W now holds 13,277 shares of the company’s stock, valued at 3,384,488. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.40%.
18 out of 22 analysts covering the stock have rated it a Buy, while 2 have maintained a Hold recommendation on Danaher Corporation. 1 analysts has assigned a Sell rating on the DHR stock. The 12-month mean consensus price target for the company’s shares has been set at $288.29.